Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Fagron NV (FAGR) NPV

Sell:€18.80 Buy:€19.25 Change: €0.40 (2.08%)
Market closed |  Prices as at close on 7 August 2020 | Switch to live prices |
Sell:€18.80
Buy:€19.25
Change: €0.40 (2.08%)
Market closed |  Prices as at close on 7 August 2020 | Switch to live prices |
Sell:€18.80
Buy:€19.25
Change: €0.40 (2.08%)
Market closed |  Prices as at close on 7 August 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in the Company's compounding facilities; the Fagron Trademarks segment encompasses concepts and formulations developed by the Company's research and development (R&D) team; Fagron Essentials comprises pharmaceutical raw materials, equipment and supplies for pharmacies, and the HL Technology segment includes the development and production of precision components and orthopedic tools for dental and medical professionals.

Contact details

Address:
Venecoweg 20A
NAZARETH
9810
Belgium
Telephone:
+32 (80) 012880
Website:
https://fagron.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
FAGR
ISIN:
BE0003874915
Market cap:
€1.39 billion
Shares in issue:
72.08 million
Sector:
Health Care Distributors
Exchange:
Euronext Brussels
Country:
Belgium
Currency:
Euro
Indices:
Euronext Next 150

Key personnel

  • koen Hoffman
    Independent Chairman of the Board representing AHOK BVBA
  • Rafael Padilla
    Chief Executive Officer, Member of the Executive Committee, Director
  • Karin de Jong
    Chief Financial Officer, Executive Director, Member of the Executive Committee
  • Constantijn van Rietschoten
    Chief Communications Officer, Member of the Executive Committee

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.